Arian Pano

Insider Reports History

Location
Hamilton, Bermuda
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact for Arian Pano
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Arian Pano:

Company Role Class Num Shares Value Price $ Report Date Ownership
Kiniksa Pharmaceuticals, Ltd. Chief Clinical Dev. Officer Share Option 23,325 02 Sep 2021 Direct
Kiniksa Pharmaceuticals, Ltd. Chief Clinical Dev. Officer Restricted Share Units 3,888 02 Sep 2021 Direct

Insider Reports Filed by Arian Pano

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KNSA Kiniksa Pharmaceuticals, Ltd. 02 Sep 2021 2 $0 4 Chief Clinical Dev. Officer 07 Sep 2021, 17:19
KNSA Kiniksa Pharmaceuticals, Ltd. 10 Jun 2021 0 $0 3 Chief Clinical Dev. Officer 21 Jun 2021, 17:37